278 related articles for article (PubMed ID: 17656824)
1. Phagocytosis of amyloid-beta and inflammation: two faces of innate immunity in Alzheimer's disease.
Fiala M; Cribbs DH; Rosenthal M; Bernard G
J Alzheimers Dis; 2007 Jul; 11(4):457-63. PubMed ID: 17656824
[TBL] [Abstract][Full Text] [Related]
2. Re-balancing of inflammation and abeta immunity as a therapeutic for Alzheimer's disease-view from the bedside.
Fiala M
CNS Neurol Disord Drug Targets; 2010 Apr; 9(2):192-6. PubMed ID: 20205641
[TBL] [Abstract][Full Text] [Related]
3. The NALP3 inflammasome is involved in the innate immune response to amyloid-beta.
Halle A; Hornung V; Petzold GC; Stewart CR; Monks BG; Reinheckel T; Fitzgerald KA; Latz E; Moore KJ; Golenbock DT
Nat Immunol; 2008 Aug; 9(8):857-65. PubMed ID: 18604209
[TBL] [Abstract][Full Text] [Related]
4. Ineffective phagocytosis of amyloid-beta by macrophages of Alzheimer's disease patients.
Fiala M; Lin J; Ringman J; Kermani-Arab V; Tsao G; Patel A; Lossinsky AS; Graves MC; Gustavson A; Sayre J; Sofroni E; Suarez T; Chiappelli F; Bernard G
J Alzheimers Dis; 2005 Jun; 7(3):221-32; discussion 255-62. PubMed ID: 16006665
[TBL] [Abstract][Full Text] [Related]
5. Innate Immunity Fights Alzheimer's Disease.
Guillot-Sestier MV; Doty KR; Town T
Trends Neurosci; 2015 Nov; 38(11):674-681. PubMed ID: 26549882
[TBL] [Abstract][Full Text] [Related]
6. Omega-3 fatty acids enhance phagocytosis of Alzheimer's disease-related amyloid-β42 by human microglia and decrease inflammatory markers.
Hjorth E; Zhu M; Toro VC; Vedin I; Palmblad J; Cederholm T; Freund-Levi Y; Faxen-Irving G; Wahlund LO; Basun H; Eriksdotter M; Schultzberg M
J Alzheimers Dis; 2013; 35(4):697-713. PubMed ID: 23481688
[TBL] [Abstract][Full Text] [Related]
7. The role of innate immune responses and neuroinflammation in amyloid accumulation and progression of Alzheimer's disease.
Webers A; Heneka MT; Gleeson PA
Immunol Cell Biol; 2020 Jan; 98(1):28-41. PubMed ID: 31654430
[TBL] [Abstract][Full Text] [Related]
8. Cross Talk Between Brain Innate Immunity and Serotonin Signaling Underlies Depressive-Like Behavior Induced by Alzheimer's Amyloid-β Oligomers in Mice.
Ledo JH; Azevedo EP; Beckman D; Ribeiro FC; Santos LE; Razolli DS; Kincheski GC; Melo HM; Bellio M; Teixeira AL; Velloso LA; Foguel D; De Felice FG; Ferreira ST
J Neurosci; 2016 Nov; 36(48):12106-12116. PubMed ID: 27903721
[TBL] [Abstract][Full Text] [Related]
9. A novel role for SHARPIN in amyloid-β phagocytosis and inflammation by peripheral blood-derived macrophages in Alzheimer's disease.
Krishnan D; Menon RN; Mathuranath PS; Gopala S
Neurobiol Aging; 2020 Sep; 93():131-141. PubMed ID: 32165044
[TBL] [Abstract][Full Text] [Related]
10. Deglycosylated anti-amyloid beta antibodies reduce microglial phagocytosis and cytokine production while retaining the capacity to induce amyloid beta sequestration.
Takata K; Hirata-Fukae C; Becker AG; Chishiro S; Gray AJ; Nishitomi K; Franz AH; Sakaguchi G; Kato A; Mattson MP; Laferla FM; Aisen PS; Kitamura Y; Matsuoka Y
Eur J Neurosci; 2007 Nov; 26(9):2458-68. PubMed ID: 17970733
[TBL] [Abstract][Full Text] [Related]
11. Alpha7 nicotinic acetylcholine receptor-specific agonist DMXBA (GTS-21) attenuates Aβ accumulation through suppression of neuronal γ-secretase activity and promotion of microglial amyloid-β phagocytosis and ameliorates cognitive impairment in a mouse model of Alzheimer's disease.
Takata K; Amamiya T; Mizoguchi H; Kawanishi S; Kuroda E; Kitamura R; Ito A; Saito Y; Tawa M; Nagasawa T; Okamoto H; Sugino Y; Takegami S; Kitade T; Toda Y; Kem WR; Kitamura Y; Shimohama S; Ashihara E
Neurobiol Aging; 2018 Feb; 62():197-209. PubMed ID: 29175709
[TBL] [Abstract][Full Text] [Related]
12. The antimicrobial protection hypothesis of Alzheimer's disease.
Moir RD; Lathe R; Tanzi RE
Alzheimers Dement; 2018 Dec; 14(12):1602-1614. PubMed ID: 30314800
[TBL] [Abstract][Full Text] [Related]
13. Environmental Enrichment Potently Prevents Microglia-Mediated Neuroinflammation by Human Amyloid β-Protein Oligomers.
Xu H; Gelyana E; Rajsombath M; Yang T; Li S; Selkoe D
J Neurosci; 2016 Aug; 36(35):9041-56. PubMed ID: 27581448
[TBL] [Abstract][Full Text] [Related]
14. Modeling Alzheimer's disease immune therapy mechanisms: interactions of human postmortem microglia with antibody-opsonized amyloid beta peptide.
Lue LF; Walker DG
J Neurosci Res; 2002 Nov; 70(4):599-610. PubMed ID: 12404514
[TBL] [Abstract][Full Text] [Related]
15. The adaptive immune system restrains Alzheimer's disease pathogenesis by modulating microglial function.
Marsh SE; Abud EM; Lakatos A; Karimzadeh A; Yeung ST; Davtyan H; Fote GM; Lau L; Weinger JG; Lane TE; Inlay MA; Poon WW; Blurton-Jones M
Proc Natl Acad Sci U S A; 2016 Mar; 113(9):E1316-25. PubMed ID: 26884167
[TBL] [Abstract][Full Text] [Related]
16. LPS receptor (CD14): a receptor for phagocytosis of Alzheimer's amyloid peptide.
Liu Y; Walter S; Stagi M; Cherny D; Letiembre M; Schulz-Schaeffer W; Heine H; Penke B; Neumann H; Fassbender K
Brain; 2005 Aug; 128(Pt 8):1778-89. PubMed ID: 15857927
[TBL] [Abstract][Full Text] [Related]
17. TLR2 is a primary receptor for Alzheimer's amyloid β peptide to trigger neuroinflammatory activation.
Liu S; Liu Y; Hao W; Wolf L; Kiliaan AJ; Penke B; Rübe CE; Walter J; Heneka MT; Hartmann T; Menger MD; Fassbender K
J Immunol; 2012 Feb; 188(3):1098-107. PubMed ID: 22198949
[TBL] [Abstract][Full Text] [Related]
18. Inflammation in Alzheimer's disease: amyloid-beta oligomers trigger innate immunity defence via pattern recognition receptors.
Salminen A; Ojala J; Kauppinen A; Kaarniranta K; Suuronen T
Prog Neurobiol; 2009 Feb; 87(3):181-94. PubMed ID: 19388207
[TBL] [Abstract][Full Text] [Related]
19. Mimicry of Central-Peripheral Immunity in Alzheimer's Disease and Discovery of Neurodegenerative Roles in Neutrophil.
Park J; Baik SH; Mook-Jung I; Irimia D; Cho H
Front Immunol; 2019; 10():2231. PubMed ID: 31611872
[TBL] [Abstract][Full Text] [Related]
20. Mutated Toll-like receptor 9 increases Alzheimer's disease risk by compromising innate immunity protection.
Cacace R; Zhou L; Hendrickx Van de Craen E; Buist A; Hoogmartens J; Sieben A; Cras P; Vandenberghe R; De Deyn PP; Oehlrich D; De Bondt A; Engelborghs S; Moechars D; Van Broeckhoven C
Mol Psychiatry; 2023 Dec; 28(12):5380-5389. PubMed ID: 37433968
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
